Loading...
Loading...
Stifel Nicolaus maintained Team Health Holdings
TMH with a Buy rating and raised the price target from $35.00 to $37.00.
Stifel Nicolaus commented, "Team Health Holdings reported fourth quarter EPS of $0.39, ahead of our at-consensus $0.36 estimate, aided by both the severe flu season and a lower-than-expected tax rate. We are raising our earnings estimates and target price, as we expect the company will continue to grow internally, via new contracts, and through accretive acquisitions, likely complemented by Medicaid parity (though we exclude this benefit from our estimates)."
Team Health Holdings closed at $33.74 on Tuesday.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in